Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy
Authors:
- 24 April 2011
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 18 (6) , 415-423
Abstract
Summary. The hepatitis B virus (HBV) replicates via an error‐prone reverse transcriptase generating potential drug‐resistant quasispecies. The degree of HBV variability in liver vs peripheral blood mononuclear cells (PBMC) in patients on long‐term suppressive antivirals is unclear. We characterized HBV replication, drug resistance and molecular diversity in patients with plasma HBV DNA undetectable by clinical assays. Explant liver (n = 9), PBMC (n = 6) and plasma (n = 7) from nine such patients undergoing liver transplantation were evaluated for HBV genomes by sensitive PCR/nucleic acid hybridization assay. Cases with HBV DNA in liver and PBMC were tested for covalently closed circular DNA (HBV cccDNA). HBV polymerase (P) amplicons were cloned, sequenced and both P and overlapping surface (S) gene sequences were analysed. HBV DNA was detected in 43% (3/7) of plasma, 100% (9/9) of liver and 83% (5/6) of PBMC samples. HBV cccDNA was detected in all liver and one PBMC sample. Four patients had a clinical diagnosis of resistance. HBV P gene sequencing revealed 100% wild type (wt) in plasma (2/2), 83% wt in PBMC (5/6) but livers of 3/9 (33%) contained wt and 6/9 (66%) carried resistance to lamivudine and/or adefovir. The translated S gene revealed no changes affecting HBV antigenicity. Sequences from livers with antiviral resistant mutants revealed greater interpatient quasispecies diversity. Despite apparent HBV suppression, the liver continues to support HBV replication and extrahepatic HBV can be detected. PBMC may be a sanctuary for wt virus during antiviral therapy, while the liver harbours more drug‐resistant viruses. Drug resistance correlates with intrahepatic viral diversity.Keywords
This publication has 48 references indexed in Scilit:
- Genetic Characterization of Hepatitis B Virus in Peripheral Blood Leukocytes: Evidence for Selection and Compartmentalization of Viral Variants with the Immune Escape G145R MutationJournal of Virology, 2009
- The genetic backbone modulates the phenotype of hepatitis B surface antigen mutantsJournal of General Virology, 2009
- Use of Massively Parallel Ultradeep Pyrosequencing To Characterize the Genetic Diversity of Hepatitis B Virus in Drug-Resistant and Drug-Naive Patients and To Detect Minor Variants in Reverse Transcriptase and Hepatitis B S AntigenJournal of Virology, 2009
- Repeated Passage of Wild-Type Woodchuck Hepatitis Virus in Lymphoid Cells Does Not Generate Cell Type-Specific Variants or Alter Virus InfectivityJournal of Virology, 2008
- Hepatitis B viruses: Reverse transcription a different wayVirus Research, 2008
- Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failureHepatology International, 2008
- MEGA: A biologist-centric software for evolutionary analysis of DNA and protein sequencesBriefings in Bioinformatics, 2008
- Compartmentalization of the gut viral reservoir in HIV-1 infected patientsRetrovirology, 2007
- New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNAJournal of Hepatology, 2005
- Hbv Dna Persistence 10 Years After Liver Transplantation Despite Successful Anti–Hbs Passive ImmunoprophylaxisHepatology, 2003